title: The Effect of PPARalpha, PPARdelta, PPARgamma, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice.
abstract: Activation of peroxisome proliferator-activated receptor (PPAR) alpha, delta, and gamma subtypes increases expression of genes involved in fatty acid transport and oxidation and alters adiposity in animal models of obesity and type-2 diabetes. PPARpan agonists which activate all three receptor subtypes have antidiabetic activity in animal models without the weight gain associated with selective PPARgamma agonists. Herein we report the effects of selective PPAR agonists (GW9578, a PPARalpha agonist, GW0742, a PPARdelta agonist, GW7845, a PPARgamma agonist), combination of PPARalpha and delta agonists, and PPARpan (PPARalpha/gamma/delta) activators (GW4148 or GW9135) on body weight (BW), body composition, food consumption, fatty acid oxidation, and serum chemistry of diet-induced obese AKR/J mice. PPARalpha or PPARdelta agonist treatment induced a slight decrease in fat mass (FM) while a PPARgamma agonist increased BW and FM commensurate with increased food consumption. The reduction in BW and food intake after cotreatment with PPARalpha and delta agonists appeared to be synergistic. GW4148, a PPARpan agonist, induced a significant and sustained reduction in BW and FM similar to an efficacious dose of rimonabant, an antiobesity compound. GW9135, a PPARpan agonist with weak activity at PPARdelta, induced weight loss initially followed by rebound weight gain reaching vehicle control levels by the end of the experiment. We conclude that PPARalpha and PPARdelta activations are critical to effective weight loss induction. These results suggest that the PPARpan compounds may be expected to maintain the beneficial insulin sensitization effects of a PPARgamma agonist while either maintaining weight or producing weight loss.
authors: Department of Metabolic Diseases, GlaxoSmithKline Research, Research Triangle Park, NC 27709, USA.
authors: W Wallace
authors: WW
authors: Harrington
authors: Christy
authors: C
authors: S Britt
authors: Joan
authors: J
authors: G Wilson
authors: Naphtali
authors: N
authors: O Milliken
authors: Jane
authors: J
authors: G Binz
authors: David
authors: D
authors: C Lobe
authors: William
authors: W
authors: R Oliver
authors: Michael
authors: M
authors: C Lewis
authors: Diane
authors: D
authors: M Ignar
references: Horm Metab Res. 2003 Oct;35(10):617-24
references: 14605998
references: Obes Rev. 2005 Nov;6(4):283-96
references: 16246214
references: Am J Physiol. 1972 Oct;223(4):783-7
references: 5075154
references: Br J Pharmacol. 2005 Feb;144(3):308-16
references: 15655531
references: Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3444-9
references: 16492734
references: Diabetes Metab. 2005 Feb;31(1):23-7
references: 15803109
references: J Cardiovasc Risk. 2001 Aug;8(4):187-94
references: 11550996
references: Curr Opin Lipidol. 2000 Dec;11(6):627-37
references: 11086337
references: Metabolism. 2004 Sep;53(9):1121-5
references: 15334371
references: Diabetes. 2004 Mar;53(3):847-51
references: 14988273
references: Br J Pharmacol. 2003 Oct;140(3):527-37
references: 12970088
references: J Biol Chem. 2004 Oct 29;279(44):46204-12
references: 15302862
references: J Biol Chem. 1995 Jun 2;270(22):12953-6
references: 7768881
references: Am J Physiol. 1997 Jan;272(1 Pt 2):R357-62
references: 9039029
references: Mutat Res. 2000 Mar 17;448(2):121-38
references: 10725467
references: Diabetes. 2004 Feb;53 Suppl 1:S43-50
references: 14749265
references: Nat Med. 2005 Aug;11(8):861-6
references: 16007095
references: Physiol Behav. 2006 Jun 30;88(3):227-33
references: 16777151
references: Diabetes. 2003 Aug;52(8):1958-66
references: 12882911
references: Endocrine. 2006 Feb;29(1):33-48
references: 16622291
references: Nutr J. 2004 Apr 14;3:3
references: 15084221
references: Curr Opin Lipidol. 2003 Dec;14(6):651-2
references: 14624145
references: Cell. 2005 Dec 16;123(6):993-9
references: 16360030
references: Mol Cell. 1999 Mar;3(3):397-403
references: 10198642
references: Diabetes. 2003 Sep;52(9):2331-7
references: 12941773
references: Expert Opin Emerg Drugs. 2006 Sep;11(3):379-401
references: 16939380
references: J Med Chem. 1999 Sep 23;42(19):3785-8
references: 10508427
references: Biochimie. 2004 Nov;86(11):833-7
references: 15589693
references: Endocrinology. 1996 Jan;137(1):354-66
references: 8536636
references: J Biol Chem. 2002 Jul 19;277(29):26089-97
references: 12118038
references: Diabetes. 2003 Sep;52(9):2249-59
references: 12941763
references: Metabolism. 2003 Aug;52(8):1078-83
references: 12898477
references: Cell Growth Differ. 2000 May;11(5):231-7
references: 10845423
references: Obes Res. 2004 Oct;12(10):1604-15
references: 15536224
references: Annu Rev Nutr. 2002;22:167-97
references: 12055342
references: J Biol Chem. 2000 Jun 2;275(22):16638-42
references: 10828060
references: Curr Med Res Opin. 2004 Jun;20(6):919-30
references: 15200751
references: Diabetes. 2000 May;49(5):759-67
references: 10905484
references: J Lipid Res. 2004 Apr;45(4):616-25
references: 14703507
references: Curr Opin Cell Biol. 1998 Apr;10(2):165-73
references: 9561840
references: J Nutr. 2002 Nov;132(11):3325-32
references: 12421846
references: Endocrinology. 2001 Mar;142(3):1269-77
references: 11181544
references: Curr Mol Med. 2005 May;5(3):349-63
references: 15892654
references: J Clin Endocrinol Metab. 2004 Jun;89(6):2616-21
references: 15181032
references: Ann N Y Acad Sci. 2002 Jun;967:7-18
references: 12079830
references: J Med Chem. 1998 Dec 3;41(25):5020-36
references: 9836620
references: Drug News Perspect. 2004 Dec;17(10):661-9
references: 15696231
references: Am J Physiol. 1992 Jun;262(6 Pt 2):R1025-32
references: 1621856
references: Horm Metab Res. 2004 Apr;36(4):226-30
references: 15114521
references: Diabetes. 1998 Apr;47(4):507-14
references: 9568680
references: Atherosclerosis. 1998 Apr;137 Suppl:S75-80
references: 9694545
references: J Med Chem. 2000 Feb 24;43(4):527-50
references: 10691680
references: FEBS Lett. 2000 May 19;473(3):333-6
references: 10818235
references: Endocr Pract. 2003 Sep-Oct;9(5):406-16
references: 14583425
references: Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5306-11
references: 11309497
references: Int J Obes Relat Metab Disord. 2003 Dec;27 Suppl 3:S17-21
references: 14704738
references: Mini Rev Med Chem. 2006 May;6(5):563-73
references: 16719831
references: FASEB J. 2004 Feb;18(2):347-9
references: 14656998
references: Bioorg Med Chem Lett. 2003 May 5;13(9):1517-21
references: 12699745
references: PLoS Biol. 2004 Oct;2(10):e294
references: 15328533
references: Nat Med. 2004 Apr;10(4):355-61
references: 15057233
references: Prostaglandins Leukot Essent Fatty Acids. 1999 May-Jun;60(5-6):339-43
references: 10471118
references: World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
references: 11234459
references: Chem Biol. 1997 Dec;4(12):909-18
references: 9427656
references: Anal Biochem. 1998 Mar 15;257(2):112-9
references: 9514791
references: BMC Pharmacol. 2004 Oct 18;4:23
references: 15491498
references: Clin Ther. 2003;25 Suppl B:B4-31
references: 14553864
references: Ann Med. 1999 Oct;31(5):342-51
references: 10574507
references: Cell. 2003 Apr 18;113(2):159-70
references: 12705865
references: J Physiol Biochem. 2006 Jun;62(2):137-47
references: 17217167
references: Mol Cell Biochem. 1997 Sep;174(1-2):61-6
references: 9309666
references: Diabetes Care. 1996 Feb;19(2):151-6
references: 8718436
references: Eur J Cardiovasc Prev Rehabil. 2004 Feb;11(1):3-8
references: 15167200